Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Genetics researcher Alan Beggs, PhD, and his team are exploring how genes influence neuromuscular disorders. They hope to use this knowledge to develop new diagnostics and therapies.
Clinical trials are studies that may involve:
If your physician recommends that your child participate in a clinical trial, you can feel confident that the plan detailed for that study represents the best and most innovative care. Taking part in a clinical trial at Children’s is entirely voluntary. Our team will be sure to fully address any questions you may have, and you may remove your child from the medical study at any time.
Search current and upcoming clinical trials at Children’s.
Laboratory discoveries by a Boston Children’s neurologist that detail the physiology and biochemistry of a baby's brain have recently explained why most infants seem immune to anticonvulsants. This finding has led Janet Soul, MD, director of Children’s Fetal-Neonatal Neurology Program, to develop new treatments specific to infant biology, including a pilot study of bumetanide to treat newborns experiencing early seizures.
Read more about the evolution of this clinical trial.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”